Alzheimer’s has long been considered irreversible, but new research challenges that assumption. Scientists discovered that severe drops in the brain’s energy supply help drive the disease—and ...
The liver is the second largest organ in the body. It can regrow itself and remove toxins from the blood. Caught in 4K The boomers are turning 80. Now they want to change old age. 7 claims about House ...
This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. Several years ago, nephrologists attempted ...
Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Several years ago, nephrologists attempted a first-of-its-kind effort ...
The gut microbiome offers a unique snapshot of each individual, shaped by genetics, environmental exposures, lifestyle habits, and the body’s own physiology. “If you take two different individuals, it ...
Periodontal disease is a chronic inflammatory condition of the periodontal tissues, encompassing pathologies such as gingivitis and periodontitis. It has been shown that these conditions not only lead ...
Researchers at Baylor College of Medicine have discovered a natural mechanism that clears existing amyloid plaques in the brains of mouse models of Alzheimer’s disease and preserves cognitive function ...
NEW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection fraction improved cardiac function and reduced the risks for serious medical ...
RNA interference using small interfering RNAs (siRNAs) has become a mainstay of functional gene characterization and has generated over a dozen FDA-approved therapeutics and drugs in late-stage ...
Prefer Newsweek on Google to see more of our trusted coverage when you search. Scientists have achieved a “striking” reversal of Alzheimer’s disease in mice by restoring the normal function of the ...
Roche, in collaboration with KlinRisk, Inc, has received CE-mark for the first AI-based risk stratification tool for assessment of progressive decline in kidney function. This tool will be launched as ...